PT-141
AED 990.00
- Pregnancy or breastfeeding
- Children or adolescents
- Active cancer or neoplasm
- Severe liver or kidney disease
- Autoimmune disorders
- Concurrent insulin or oral hypoglycemics
PT-141, also known as Bremelanotide, is a medication primarily used to treat low sexual desire Hypoactive Sexual Desire Disorder in women (HSDD) , and it has also been studied for erectile dysfunction (ED) in men. PT-141 is a melanocortin receptor agonist, specifically targeting MC-4 and MC-3 receptors in the brain. MC3R and MC4R receptors are in the hypothalamus a key brain region involved in sexual behaviour, these receptors regulate sexual arousal.
- Increased sexual desire (libido)
- May help some men with erectile dysfunction
